title: [Presynaptic effects of arachidonic acid and prostaglandin E2 in the frog neuromuscular synapse].
abstract: Arachidonic acid and prostaglandin E2 decreased the frequency of miniature endplate currents without changing their amplitude-temporary parameters. They also reduced the evoked transmitter release and the amplitude of the 3rd phase of nerve ending response corresponding to the voltage-dependent K(+)-current. Using perineural recording, It was shown that arachidonic acid and prostaglandin E2 decreased the Ca2+ currents of nerve endings. Indometacin: inhibitor of cyclooxygenase, enhanced the evoked transmitter release and decreased the 3rd phase of nerve ending response. Indometacin prevented the effects of arachidonic acid on evoked transmitter release, whereas the effects of arachidonic acid on the 3rd phase was preserved. Prostaglandin E2 seems to mediate the effects of arachidonic acid on spontaneous and evoked transmitter release, Ca(2+)- and Ca(2+)-activated K(+)-currents. Moreover, the arachidonic acid and prostaglandin E2 exerted their own effects upon voltage-dependent potassium current of motor nerve ending.
authors.forename: O V
authors.initials: OV
authors.lastname: Arkhipova
authors.forename: S N
authors.initials: SN
authors.lastname: Grishin
authors.forename: G F
authors.initials: GF
authors.lastname: Sitdikova
authors.forename: A L
authors.initials: AL
authors.lastname: Zefirov
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000200:Action Potentials; D000818:Animals; D016718:Arachidonic Acid / Q000494:pharmacology / Q000502:physiology*; D002118:Calcium / Q000502:physiology; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000494:pharmacology / Q000502:physiology*; D004594:Electrophysiology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D009045:Motor Endplate / Q000187:drug effects / Q000502:physiology; D018482:Muscle, Skeletal / Q000294:innervation; D009469:Neuromuscular Junction / Q000187:drug effects / Q000502:physiology*; D015221:Potassium Channels / Q000502:physiology; D024642:Potassium Channels, Voltage-Gated / Q000502:physiology*; D017729:Presynaptic Terminals / Q000187:drug effects / Q000502:physiology*; D011895:Rana ridibunda
chemical_list: D016861:Cyclooxygenase Inhibitors; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D016718:Arachidonic Acid; D015232:Dinoprostone; D000109:Acetylcholine; D002118:Calcium; D007213:Indomethacin